Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry
Journal of Global Antimicrobial Resistance(2021)
摘要
•Use of ceftobiprole in Canadian patients using data captured by the CLEAR registry.•Ceftobiprole is used as directed therapy to treat a variety of severe infections caused by MRSA.•Ceftobiprole is primarily used in patients failing previous antimicrobials.•Ceftobiprole is frequently added to, and thus used in combination with, daptomycin or vancomycin.•Ceftobiprole shows high microbiological and clinical cure rates along with an excellent safety profile.
更多查看译文
关键词
Ceftobiprole,CLEAR registry,Efficacy,Adverse effects,Pneumonia,Endocarditis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要